|
NBIX
|
Neurocrine Biosciences, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
0.67%
|
US
|
NASDAQ
|
|
SYNH
|
Syneos Health, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
0.57%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.47%
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
0.46%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.43%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.41%
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
0.41%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
0.38%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.36%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.36%
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.34%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.34%
|
US
|
NASDAQ
|